Evidence map›Paper›PMID 42124438›Full record

ArticleChemistry & biodiversity2026

Comprehensive Profiling of Acetylcholinesterase Inhibitors From Cimicifuga foetida Using Activity-Oriented Offline Preparation Technology.

Yang Zhou, Qiang Liu, Xuanlin Liu, Sainan Li, Dongfang Shi, Yuchi Zhang

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yang ZhouCentral Laboratory, Changchun Normal University, Changchun, China.
Qiang LiuCentral Laboratory, Changchun Normal University, Changchun, China.
Xuanlin LiuCentral Laboratory, Changchun Normal University, Changchun, China.
Sainan LiCentral Laboratory, Changchun Normal University, Changchun, China.ORCID https://orcid.org/0000-0002-0894-6293
Dongfang ShiCentral Laboratory, Changchun Normal University, Changchun, China.
Yuchi ZhangCentral Laboratory, Changchun Normal University, Changchun, China.

Funding

Natural Science Foundation of Jilin Province 20240602028RC
6 · The paper itself

Abstract

Owing to the complexity and diversity of chemical constituents in natural food ingredients, functional food research has long faced two major technical challenges: the rapid and accurate screening of bioactive compounds, and their targeted preparation. This study aimed to establish an efficient strategy for screening and preparing acetylcholinesterase inhibitors (AChEIs) from Cimicifuga foetida (C. foetida) to improve the efficiency of fungal food preparation. First, the extraction process of C. foetida was optimized using the Non-dominated Sorting Genetic Algorithm II (NSGA-II) regression model. Next, the potential anti-Alzheimer's effects of the extracted active compounds were evaluated by affinity-ultrafiltration mass spectrometry (AUF-MS), molecular docking, enzyme kinetics, and network pharmacology analyses. Five compounds, namely cimifugin, cimifugoside, caffeic acid, ferulic acid, and isoferulic acid, exhibited strong binding affinity to the active site of AChEIs. These findings highlight the potential of C. foetida as a valuable source for the discovery and development of novel therapeutic agents from natural food resources.

Indexed as

AcetylcholinesteraseCholinesterase InhibitorsCimicifugaHumansKineticsMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipAcetylcholinesteraseCholinesterase Inhibitorsacetylcholinesterase inhibitors (AChEIs)Cimicifuga foetida (C. foetida)molecular docking techniquenetwork pharmacologyUNIFAC mathematical model

Identifiers

PMID42124438
PMCPMC13376438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.